VTRS - Viatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
2024-06-11 18:03:08 ET
Viatris Inc. (VTRS)
Goldman Sachs 45th Annual Global Healthcare Conference
June 11, 2024 09:20 AM ET
Company Participants
Scott Smith - CEO
Theodora Mistras - CFO
Philippe Martin - Chief R&D Officer
Conference Call Participants
Nathan Rich - Goldman Sachs
Presentation
Nathan Rich
Great. Why don't we get started? Thanks, everyone, for joining us. My name is Nathan Rich, I cover the generic and specialty pharma space for Goldman Sachs. Very pleased to have the Viatris team with us today. Going from my left to right, Scott Smith, CEO; Doretta Mistras, CFO; and Philippe Martin, Chief R&D Officer. Thank you all so much for being here. I really appreciate the time.
Scott Smith
Thanks, Nathan.
Question-and-Answer Session
Q - Nathan Rich
Scott, maybe starting with you. Could you kind of take us through the strategic transformation at a high level. And I think as you look forward, kind of what are the priorities for the company for the next few years and what are kind of the keys to delivering kind of sustainable growth over time?
Scott Smith
So, first of all, I just want to say that -- just a reminder that I'm going to say some forward-looking things. We are towards the end of Q2 here. So I won't be talking about Q2 or any changes or movement on our guidance. So when I look at '24, I think it's a little bit of a transition year for us. We are finishing our divestitures and we're moving into really Phase II of the strategic plan. When I think about where we are, I'm very, very pleased with where the company is....
Viatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)